Nexalin Technology (NXL) Asset Utilization Ratio (2022 - 2026)
Nexalin Technology (NXL) recorded quarterly Asset Utilization Ratio of 0.07 in Q1 2026, up 7.06% quarter-over-quarter from 0.06 in Q4 2025, and up 79.79% on a YoY basis from 0.04 in Q1 2025.
Nexalin Technology (NXL) Asset Utilization Ratio (2022 - 2026) Analysis & Trends
Nexalin Technology's Asset Utilization Ratio history runs 5 years deep, the most recent figure standing at 0.07 for Q1 2026.
- In Q1 2026, Asset Utilization Ratio rose 79.79% year-over-year to 0.07; the TTM figure through Mar 2026 stood at 0.07 (up 79.79% YoY), while the FY2025 annual figure was 0.07, up 58.53% from the prior year.
- Asset Utilization Ratio was 0.07 for Q1 2026 at Nexalin Technology, up from 0.06 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.17 in Q4 2022 to a low of 0.03 in Q3 2023.
- Historically, Asset Utilization Ratio has averaged 0.07 across 5 years, with a median of 0.05 in 2024.
- The sharpest annual moves came in 2023 and 2026: Asset Utilization Ratio plunged 83.6% in 2023, then surged 79.79% in 2026.
- A 5-year view of Asset Utilization Ratio shows it stood at 0.17 in 2022, then slumped by 83.6% to 0.03 in 2023, then rose by 29.62% to 0.04 in 2024, then jumped by 73.63% to 0.06 in 2025, then climbed by 7.06% to 0.07 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.07 (Q1 2026), 0.06 (Q4 2025), and 0.03 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 0.46 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 0.54 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 0.39 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 0.47 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 0.47 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.65 |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 0.74 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 0.57 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 0.56 |
| 10 | Nexalin Technology | 7.82 Mn | 5.11 Mn | 13,133.00 | 0.07 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.07 |
| Dec 31, 2025 | 0.06 |
| Sep 30, 2025 | 0.03 |
| Jun 30, 2025 | 0.04 |
| Mar 31, 2025 | 0.04 |
| Dec 31, 2024 | 0.04 |
| Sep 30, 2024 | 0.05 |
| Jun 30, 2024 | 0.07 |
| Mar 31, 2024 | 0.05 |
| Dec 31, 2023 | 0.03 |
| Sep 30, 2023 | 0.03 |
| Jun 30, 2023 | 0.12 |
| Mar 31, 2023 | 0.15 |
| Dec 31, 2022 | 0.17 |